Therefore, it was surprising to see that a high frequency of GARPNU+ tumor cells was linked to reduced overall survival, despite the observed upregulation of GARPNU+ in differentiation-promoting conditions (NB-bFGF/-EGF) (Figure 3B). This evidence concerns the gene FGF2 and neoplasm.